Shareholders meeting

July 09, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai-400001 Complex, Bandra (East), Mumbai-400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Proceedings of the 22nd Annual General Meeting Ref.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Annual General Meeting (AGM) of the Company was held on Thursday, July 09, 2026 through Video Conferencing / Other Audio Visual Means. Proceedings: a) Requisite quorum was present; b) All the Board Members were present; c) The following resolutions as mentioned in the Notice of the 22nd AGM were passed through remote e-voting: 1. To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon for the financial year ended March 31, 2026. 2. To declare final dividend of ₹ 10/- each (Rupees Ten each) (100%) per Equity Share having face value of ₹ 10/- each (Rupees Ten each) for the F.Y. 2025-26. 3. To appoint a Director in place of Mr. Nirav Mehta (DIN: 01644041), who retires by rotation and being eligible, offers himself for re-appointment. 4. To appoint M/s. Walker Chandiok & Co LLP, Chartered Accountants, as the Statutory Auditors of the Company and to fix their remuneration. 5. To ratify the remuneration payable to the Cost Auditors for the F.Y. 2026-27. 6. To appoint M/s. Dhara Patel, Company Secretary Firm as Secretarial Auditors of the Company. 7. To approve payment of commission to the Non Executive Directors of the Company. 8. To approve payment of remuneration to Dr. Kirtikumar Mehta (DIN: 00385658), Non Executive Director and Chairman of the Company for the Financial Year 2026-27. 9. Re-appointment of Dr. Kirtikumar Mehta (DIN: 00385658) as Non Executive Director and Chairman of the Company for a term of 5 (five) years. Declaration of Results of Voting along with Scrutinizer’s Report and Results of voting as required under Regulation 44(3) of Listing Obligations and Disclosure Requirements) Regulations, 2015 will be disclosed to the Stock Exchanges separately. The AGM commenced at 11:00 a.m. and concluded at 11:45 a.m. This outcome is also being made available on the website of the Company at www.coronaremedies.com You are requested to take note of the above. Thanking you. Yours faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer